GlassScriptPhysician profile
George S Hurt
NPI 1831243542
$676.88
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $191 · 2021: $146.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $333.80 | 2019-2021 | |
| Janssen Biotech, INC. | $122.99 | 2019-2021 | |
| Neotract INC. | $63.39 | 2019-2020 | |
| Blue Earth Diagnostics | $35.93 | 2019-2020 | |
| Myovant Sciences INC. | $34.41 | 2021 | |
| Pfizer INC. | $27.62 | 2019 | |
| Boston Scientific Corporation | $18.35 | 2019 | |
| Teleflex LLC | $15.75 | 2021 | |
| Dentsply Ih INC. | $13.11 | 2019 | |
| Coloplast Corp | $11.53 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Hurt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.